PDF(1682 KB)
PDF(1682 KB)
PDF(1682 KB)
过表达髓样细胞触发受体2对过敏性哮喘小鼠气道炎症及气道重塑的影响
Effect of triggering receptor expressed on myeloid cells 2 overexpression on airway inflammation and remodeling in mice with allergic asthma
目的 探讨过表达髓样细胞触发受体2 （TREM-2）对哮喘模型小鼠气道炎症及气道重塑的影响。方法 将40只BALB/c小鼠随机分成空白对照组、哮喘组、空载体组和TREM-2过表达组 （n=10）。采用卵白蛋白 （OVA）致敏及激发建立哮喘模型，对照组以生理盐水替代致敏液，空载体组和TREM-2过表达组分别转染腺病毒载体和TREM-2腺病毒。采用RT-PCR和Western blot法检测TREM-2、基质金属蛋白酶 （MMP）-2、MMP-9、解整合素-金属蛋白酶 （ADAM）33和ADAM8的表达。收集各组支气管肺泡灌洗液进行细胞计数、分类。酶联免疫吸附试验 （ELISA）检测血清总IgE水平及BALF中细胞因子水平。结果 与对照组相比，哮喘组小鼠TREM-2 mRNA及蛋白水平均有所下降 （P < 0.05）；Th2细胞因子及总IgE水平升高 （P < 0.05）；总细胞数及分类细胞数增多 （P < 0.05）。与哮喘组相比，过表达TREM-2组Th2细胞因子及总IgE水平下降 （P < 0.05）；总细胞及分类细胞数减少 （P < 0.05）；与气道重塑相关的MMP-2、MMP-9、TGF-β1、ADAM8和ADAM33的mRNA及蛋白表达均下调 （P < 0.05）。结论 TREM-2过表达减轻哮喘小鼠的气道炎症和气道重塑，从而为儿童哮喘的防治提供潜在的新靶点。
Objective To investigate the effect of triggering receptor expressed on myeloid cells 2 (TREM-2) overexpression on airway inflammation and remodeling in mice with asthma. Methods A total of 40 BALB/c mice were randomly divided into normal control, asthma, empty vector, and TREM-2 overexpression groups (n=10 each). Ovalbumin (OVA) sensitization and challenge were performed to establish the model of asthma. The mice in the control group were given normal saline, and those in the empty vector and TREM-2 overexpression groups were transfected with adenovirus vector and TREM-2 adenovirus, respectively. RT-PCR and Western blot were used to measure the expression of TREM-2, MMP-2, MMP-9, ADAM33, and ADAM8. Bronchoalveolar lavage fluid (BALF) was collected to perform cell counting and classification. ELISA was used to measure the total serum level of IgE and the levels of cytokines in BALF. Results Compared with the control group, the asthma group showed significant reductions in the mRNA and protein expression of TREM-2 (P < 0.05), a significantly increased level of Th2 cytokine (P < 0.05), and significantly increased numbers of total cells and classified cells. Compared with the asthma group, the TREM-2 overexpression group showed a significantly reduced level of Th2 cytokine (P < 0.05), a significantly reduced level of IgE (P < 0.05), and significantly reduced numbers of total cells and classified cells (P < 0.05), as well as significantly downregulated expression of the inflammatory factors and growth factors MMP-2, MMP-9, TGF-β1, ADAM8, and ADAM33 (P < 0.05). Conclusions TREM-2 overexpression significantly alleviates airway inflammation and airway remodeling in mice with asthma and may become a potential target for the prevention and treatment of childhood asthma.
髓样细胞触发受体2 / 哮喘 / 气道炎症 / 气道重塑 / 小鼠
Triggering receptor expressed on myeloid cells 2 / Asthma / Airway inflammation / Airway remodeling / Mice
[1] Lazarus SC. Inflammation, inflammatory mediators, and mediator antagonists in asthma[J]. J Clin Pharmacol, 1998, 38(7):577-582.
[2] Bouchon A, Dietrich J, Colonna M. Cutting edge:inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes[J]. J Immunol, 2000, 164(10):4991-4995.
[3] Bleharski JR, Kiessler V, Buonsanti C, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response[J]. J Immunol, 2003, 170(7):3812-3818.
[4] Jiang H, Xie Y, Abel PW, et al. Regulator of G-protein signaling 2 repression exacerbates airway hyper-responsiveness and remodeling in asthma[J]. Am J Respir Cell Mol Biol, 2015, 53(1):42-49.
[5] 沈叶菊, 陈晓兵, 石远峰, 等. 乌司他丁对急性肺损伤大鼠肺TLR4及TREM-1和TREM-2表达的影响[J]. 江苏医药, 2015, 41(17):2002-2005.
[6] 李美容, 王敏. 哮喘小鼠模型的建立与评价[J]. 临床肺科杂志, 2011, 16(5):664-665.
[7] Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma[J]. Front Microbiol, 2013, 4:263.
[8] Prieto J, Van Der Ploeg I, Roquet A, et al. Cytokine mRNA expression in patients with mild allergic asthma following low dose or cumulative dose allergen provocation[J]. Clin Exp Allergy, 2001, 31(5):791-800.
[9] Ohbayashi H, Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma[J]. Curr Drug Targets, 2005, 4(2):177-181.
[10] Yang YC, Zhang N, Van Crombruggen K, et al. Transforming growth factor-beta1 in inflammatory airway disease:a key for understanding inflammation and remodeling[J]. Allergy, 2012, 67(10):1193-1202.
[11] Xiong YY, Wang JS, Wu FH, et al. The effects of (±)-Praeruptorin A on airway inflammation, remodeling and transforming growth factor-β1/Smad signaling pathway in a murine model of allergic asthma[J]. Int Immunopharmacol, 2012, 14(4):392-400.
[12] Knolle MD, Owen CA. ADAM8:a new therapeutic target for asthma[J]. Expert Opin Ther Targets, 2009, 13(5):523-540.
[13] Van Eerdewegh P, Little RD, Dupuis J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness[J]. Nature, 2002, 418(6896):426-430.
